Seminars in Hematology
Volume 47, Issue 2 , Pages 133-142 , April 2010

Rituximab in Indolent Lymphomas

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J.F. is a Scholar in Clinical Research of the Leukemia & Lymphoma Society, and is supported in part by the University of Rochester SPORE in Lymphoma (1P50CA130805).

PII: S0037-1963(10)00004-1

doi: 10.1053/j.seminhematol.2010.01.003

Seminars in Hematology
Volume 47, Issue 2 , Pages 133-142 , April 2010

Article Tools

* Image Usage & Resolution